ELV
Elevance Health, Inc.
NYSE: ELV · Indianapolis, IN · Healthcare
$328.11+8.75 (+2.74%)Closed
Market Cap$72.42B
Cash$9.49Bmost recent
Runwayprofitable
P/E (TTM)13.0EPS $25.21
52-Wk Range$270.10 – $419.83
Avg Volume1.9M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$328.11-36.1%
Pipeline
Drug candidates sponsored by Elevance Health · ClinicalTrials.gov
| Phase | Drug / Candidate | Indications | Status | Next Completion | Trials | |
|---|---|---|---|---|---|---|
| N/A | Unnamed | Asthma | Completed | 2022-11-04past | 1 |
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for ELV. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.